572 related articles for article (PubMed ID: 31400254)
21. Low-level laser therapy and narrative review of other treatment modalities in androgenetic alopecia.
Galadari H; Shivakumar S; Lotti T; Wollina U; Goren A; Rokni GR; Grabbe S; Goldust M
Lasers Med Sci; 2020 Aug; 35(6):1239-1244. PubMed ID: 32162134
[TBL] [Abstract][Full Text] [Related]
22. Molecular mechanisms of androgenetic alopecia.
Trüeb RM
Exp Gerontol; 2002; 37(8-9):981-90. PubMed ID: 12213548
[TBL] [Abstract][Full Text] [Related]
23. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z
Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165
[TBL] [Abstract][Full Text] [Related]
24. Androgenetic alopecia in transgender and gender diverse populations: A review of therapeutics.
Gao JL; Streed CG; Thompson J; Dommasch ED; Peebles JK
J Am Acad Dermatol; 2023 Oct; 89(4):774-783. PubMed ID: 34756934
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
Blume-Peytavi U; Issiakhem Z; Gautier S; Kottner J; Wigger-Alberti W; Fischer T; Hoffmann R; Tonner F; Bouroubi A; Voisard JJ
J Cosmet Dermatol; 2019 Feb; 18(1):215-220. PubMed ID: 29659116
[TBL] [Abstract][Full Text] [Related]
26. Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness.
Sinclair R; Patel M; Dawson TL; Yazdabadi A; Yip L; Perez A; Rufaut NW
Br J Dermatol; 2011 Dec; 165 Suppl 3():12-8. PubMed ID: 22171680
[TBL] [Abstract][Full Text] [Related]
27. A mouse model of androgenetic alopecia.
Crabtree JS; Kilbourne EJ; Peano BJ; Chippari S; Kenney T; McNally C; Wang W; Harris HA; Winneker RC; Nagpal S; Thompson CC
Endocrinology; 2010 May; 151(5):2373-80. PubMed ID: 20233794
[TBL] [Abstract][Full Text] [Related]
28. Platelet rich plasma for the management of hair loss: Better alone or in combination?
Anitua E; Pino A; Jaén P; Navarro MR
J Cosmet Dermatol; 2019 Apr; 18(2):483-486. PubMed ID: 29904992
[TBL] [Abstract][Full Text] [Related]
29. Psychological effect, pathophysiology, and management of androgenetic alopecia in men.
Stough D; Stenn K; Haber R; Parsley WM; Vogel JE; Whiting DA; Washenik K
Mayo Clin Proc; 2005 Oct; 80(10):1316-22. PubMed ID: 16212145
[TBL] [Abstract][Full Text] [Related]
30. Dutasteride in Androgenetic Alopecia: An Update.
Arif T; Dorjay K; Adil M; Sami M
Curr Clin Pharmacol; 2017; 12(1):31-35. PubMed ID: 28294070
[TBL] [Abstract][Full Text] [Related]
31. Androgenetic alopecia and current methods of treatment.
Bienová M; Kucerová R; Fiurásková M; Hajdúch M; Koláŕ Z
Acta Dermatovenerol Alp Pannonica Adriat; 2005 Mar; 14(1):5-8. PubMed ID: 15818439
[TBL] [Abstract][Full Text] [Related]
32. Male pattern baldness.
Hogan DJ; Chamberlain M
South Med J; 2000 Jul; 93(7):657-62. PubMed ID: 10923949
[TBL] [Abstract][Full Text] [Related]
33. A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia.
Suchonwanit P; Rojhirunsakool S; Khunkhet S
Lasers Med Sci; 2019 Dec; 34(9):1857-1864. PubMed ID: 30982177
[TBL] [Abstract][Full Text] [Related]
34. Microneedling for the treatment of hair loss?
Fertig RM; Gamret AC; Cervantes J; Tosti A
J Eur Acad Dermatol Venereol; 2018 Apr; 32(4):564-569. PubMed ID: 29194786
[TBL] [Abstract][Full Text] [Related]
35. Management of androgenetic alopecia.
Tosti A; Camacho-Martinez F; Dawber R
J Eur Acad Dermatol Venereol; 1999 May; 12(3):205-14. PubMed ID: 10461639
[TBL] [Abstract][Full Text] [Related]
36. Caspase-1 level is higher in the scalp in androgenetic alopecia.
de Rivero Vaccari JP; Sawaya ME; Brand F; Nusbaum BP; Bauman AJ; Bramlett HM; Dietrich WD; Keane RW
Dermatol Surg; 2012 Jul; 38(7 Pt 1):1033-9. PubMed ID: 22404322
[TBL] [Abstract][Full Text] [Related]
37. Original article: Platelet-rich plasma with microneedling in androgenetic alopecia along with dermoscopic pre- and post-treatment evaluation.
Jha AK; Udayan UK; Roy PK; Amar AKJ; Chaudhary RKP
J Cosmet Dermatol; 2018 Jun; 17(3):313-318. PubMed ID: 28771982
[TBL] [Abstract][Full Text] [Related]
38. Androgenetic alopecia: An update.
Ntshingila S; Oputu O; Arowolo AT; Khumalo NP
JAAD Int; 2023 Dec; 13():150-158. PubMed ID: 37823040
[TBL] [Abstract][Full Text] [Related]
39. Androgenetic Alopecia in Gender Minority Patients.
Marks DH; Senna MM
Dermatol Clin; 2020 Apr; 38(2):239-247. PubMed ID: 32115134
[TBL] [Abstract][Full Text] [Related]
40. Nonsurgical hair restoration treatment.
Nazarian RS; Farberg AS; Hashim PW; Goldenberg G
Cutis; 2019 Jul; 104(1):17-24. PubMed ID: 31487342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
